tirzepatide approval FDA for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Eli Lilly's weight loss drug

Earlier this year, weight-loss focused companies including Noom and WeightWatchers -- the latter of which Winfrey owns stock in and sits on the board -- jumped into the obesity drugs market as well

Advances in local drug delivery technologies for improved rheumatoid arthritis therapy

Others consider it for muscle recovery after strain or overuse

[2] [3] The relationship between GLP-1 receptor agonists and acid reflux or gastroesophageal reflux disease (GERD) symptoms is complex

Ellagic acid metabolism by human gut microbiota: consistent observation of three urolithin phenotypes in intervention trials, independent of food source, age, and health status

doi: 10.1016/j.jconrel.2015.08.026